Lobbying activity
Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 80 filings
Top spenders & firms Spend by issue Political contributions Revolving door
Q4
COUNCIL FOR INNOVATION PROMOTION (C4IP) for COUNCIL FOR INNOVATION PROMOTION (C4IP)
Q4
ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
Q4
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Q4
AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA) for AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA)
Q4
CENTER FOR INDIVIDUAL FREEDOM for CENTER FOR INDIVIDUAL FREEDOM
Q4
MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING
Q4
PUBLIC CITIZEN for PUBLIC CITIZEN
Q4
S-3 GROUP for FRESENIUS KABI
Q4
ELITE STRATEGIC SERVICES for CONSERVATIVES FOR PROPERTY RIGHTS
Q4
RADIUS ADVOCACY, LLC for COUNCIL FOR INNOVATION PROMOTION (C4IP)
3A
FRESENIUS KABI USA LLC for FRESENIUS KABI USA LLC
Q3
AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA) for AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA)
Q3
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
Q3
WHITMER & WORRALL, LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)
Q3
ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
Q3
BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
Q3
NOVARTIS for NOVARTIS
Q3
JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
Q3
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
Q3
CENTER FOR INDIVIDUAL FREEDOM for CENTER FOR INDIVIDUAL FREEDOM
Q3
COUNCIL FOR INNOVATION PROMOTION (C4IP) for COUNCIL FOR INNOVATION PROMOTION (C4IP)
Q3
S-3 GROUP for FRESENIUS KABI
Q3
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Q3
FRESENIUS KABI USA LLC for FRESENIUS KABI USA LLC
Q3
MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING